High Throughput Screening Market Growth Drivers and Forecast by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

High Throughput Screening Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service (Consumables, Instruments, Accessories, Software, and Services), Technology (Cell-Based Assays, Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology), Application (Drug Discovery, Biochemical Screening, Life Sciences Research, and Other Applications), End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations (CRO), and Others)

  • Report Date : Sep 2021
  • Report Code : TIPBT00002085
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 246

The high throughput screening market is projected to reach US$ 28,255.71 million by 2028 from US$ 15,997.47 million in 2021. The market is estimated to grow with a CAGR of 8.5% from 2021 to 2028.

High-throughput screening (HTS) is a drug discovery method that enables automated testing of various chemical or biological compounds for a specific biological target. High-throughput screening methods are widely used in the pharmaceutical industry, leveraging robotics and automation to quickly test the biological or biochemical activity of a significant number of molecules, usually drugs. They accelerate target analysis, as large-scale compound libraries can soon be screened cost-effectively. HTS is a valuable tool for assessing pharmacological targets, pharmacologically profiling agonists, and antagonists for receptors (such as GPCRs) and enzymes. Factors such as an increase in investment in research & development by the pharmaceutical and biotechnology industry and the introduction of technologically advanced products in the high throughput screening market are expected to boost the market growth over the years. However, the high cost of high-throughput screening, lack of trained professionals, and complexity in assay development are likely to hamper the market's growth in the coming years.

Market Insights

Increase in Investment in Research and Development by Pharmaceutical and Biotechnology Industry

An increase in R&D expenditures by pharmaceutical and biotechnology companies and significant drug pipelines to treat various chronic diseases such as cardiovascular disorders, cancer, immunological disorders, metabolic disorders, and neurological disorders are notable drivers for the high throughput screening market. Several big and small pharmaceutical companies are involved in developing and manufacturing new molecules for several life-threatening diseases. This has led to the choice of automated high-throughput screening (HTS) methods to screen huge chemical libraries to engageengage the needs of ever-increasing drug target molecules. For instance, an automated high throughput screening system can screen around 10,000 to 100,000 target compounds in a single day. Pharma and biotech companies have substantially invested in high throughput screening techniques in the past decade. For instance, the famous alliance of Millennium Pharmaceuticals, Inc. and Bayer AG has successfully discovered 18 novel drug targets and brought four of them into high throughput screening in just less than eight months. The alliance adopts a novel production approach based on genomics research to get molecules into clinical trials as quickly as possible. High-throughput screening has been regarded as a vital technology in the drug discovery process. For instance, above 60% of Boehringer Ingelheim’s fully developed lead structure optimization programs are due to the successful implementation of HTS. More than 2.5 billion US dollars are annually spent on HTS products and HTS services in the US alone. Large pharmaceutical companies invest up to US$ 35 million annually in screening technologies. A significant proportion of these investments goes into the development of new assays.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

High Throughput Screening Market: Strategic Insights

high-througput-screening-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

A rising number of drug targets for screening, which is used for drug discovery and development, and growing investments by government and research institutes will further boost the adoption of HTS techniques. For instance, in December 2020, a UK-based independent integrated drug discovery and pre-clinical contract research organization, Sygnature Discovery has invested around US$ 4.12 million for strengthening its high-throughput screening (HTS) and translational oncology service. Moreover, programs like “Toxicology in the 21st Century”- a joint venture of the US FDA, Environment Protection Agency, and the US National Institute of Health-use automated HTS for testing chemicals, formulation, and environmental drugs, for an extensive toxicological examination and to develop specific pathways associated to the disease to predict the toxicological levels. Such ventures will support the proliferation of the high throughput screening market.

Product and Service-Based Insights

Based on product and service, the high throughput screening market is categorized into consumables, instruments, accessories, software, and services. In 2021, the consumables segment held the largest share of the market and is expected to witness the fastest CAGR during the forecast period.

Report Coverage



Technology-Based Insights

Based on technology, the high throughput screening market is segmented into cell-based assays, lab-on-a-chip, ultra-high-throughput screening, bioinformatics, and label-free technology. In 2021, the cell-based assays segment held the largest share of the market, whereas the lab-on-a-chip segment is expected to grow at the fastest CAGR during the forecast period.

Application-Based Insights

Based on application, the high throughput screening market is segmented into drug discovery, biochemical screening, life sciences research, and other applications. In 2021, the drug discovery segment held the largest share of the market and is expected to grow at the fastest CAGR during the forecast period.

End-User -Based Insights

Based on end-user, the high throughput screening market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CRO), and others. In 2021, the pharmaceutical and biotechnology companies segment held the largest share of the market, whereas the contract research organizations (CRO) segment is expected to grow at the fastest CAGR during the forecast period.

Various companies operating in the high throughput screening market are adopting strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain brand name, and meet the growing demand from end users.

High Throughput Screening Market Regional Insights

The regional trends and factors influencing the High Throughput Screening Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses High Throughput Screening Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

high-througput-screening-market-global-geography
  • Get the Regional Specific Data for High Throughput Screening Market

High Throughput Screening Market Report Scope

Report Attribute Details
Market size in 2021 US$ 16 Billion
Market Size by 2028 US$ 28.26 Billion
Global CAGR (2021 - 2028) 8.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product and Service
  • Consumables
  • Instruments
  • Accessories
  • Software
  • Services
By Technology
  • Cell-Based Assays
  • Lab-On-A-Chip
  • Ultra-High-Throughput Screening
  • Bioinformatics
  • Label-Free Technology
By Application
  • Drug Discovery
  • Biochemical Screening
  • Life Sciences Research
  • Other Applications
By End User
  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Institutes
  • Contract Research Organizations
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Agilent Technologies, Inc.
  • Axxam S.P.A.
  • Eurofins Scientific
  • Corning Incorporated
  • Molecular Devices, LLC.
  • Hamilton Company
  • Merck Group
  • Perkinelmer, Inc.
  • Tecan Group

  • High Throughput Screening Market Players Density: Understanding Its Impact on Business Dynamics

    The High Throughput Screening Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the High Throughput Screening Market are:

    1. Agilent Technologies, Inc.
    2. Axxam S.P.A.
    3. Eurofins Scientific
    4. Corning Incorporated
    5. Molecular Devices, LLC.

    Disclaimer: The companies listed above are not ranked in any particular order.


    high-througput-screening-market-cagr

    • Get the High Throughput Screening Market top key players overview

     

    High Throughput Screening Market – by Product and Service

    • Consumables
      • Reagents and Assay Kits
      • Laboratory Equipment
    • Instruments
      • Liquid Handling Systems
      • Detection Systems
    • Accessories
    • Software
    • Services

    High Throughput Screening Market – by Technology

    • Cell-Based Assays
    • Lab-On-A-Chip
    • Ultra-High-Throughput Screening
    • Bioinformatics
    • Label-Free Technology
      • Surface Plasmon Resonance
      • Reflective Interferometry
      • Isothermal Titration Calorimetry
      • Differential Scanning Calorimetry
      • Microcantilevers
      • Carbon Nanotubes
      • Photonic Crystals
      • Others

    High Throughput Screening Market – by Application

    • Drug Discovery
    • Biochemical Screening
    • Life Sciences Research
    • Other Applications

    High Throughput Screening Market – by End User

    • Pharmaceutical and Biotechnology Companies
    • Academic and Government Institutes
    • Contract Research Organizations (CRO)
    • Others

    High Throughput Screening Market – by Geography

    • North America

      • US
      • Canada
      • Mexico
    • Europe

      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)

      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of Asia Pacific
    • Middle East & Africa (MEA)

      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of Middle East & Africa
    • South America (SAM)

      • Brazil
      • Argentina
      • Rest of South and Central America

    Company Profiles

    • Agilent Technologies, Inc.
    • Axxam S.P.A.
    • Eurofins Scientific
    • Corning Incorporated
    • Molecular Devices, LLC.
    • Hamilton Company
    • Merck Group
    • Perkinelmer, Inc.
    • Tecan Group
    • Thermo Fisher Scientific Inc.

    Frequently Asked Questions

    What are the driving factors for the high-throughput screening market across the globe?

    Key factors that are driving the growth of this market increase in investment in research and development by the pharmaceutical and biotechnology industry and the introduction of technologically advanced products in the high throughput screening.

    Which end-user held the largest share in the high-throughput screening market?

    The pharmaceutical and biotechnology companies segment dominated the global high-throughput screening market and accounted for the largest revenue share of 45.27% in 2021.

    What are high-throughput screening?

    High-throughput screening (HTS) is a drug discovery process that allows automated testing of large numbers of chemical and/or biological compounds for a specific biological target. High-throughput screening methods are extensively used in the pharmaceutical industry, leveraging robotics and automation to quickly test the biological or biochemical activity of a large number of molecules, usually drugs. They accelerate target analysis, as large-scale compound libraries can quickly be screened in a cost-effective way. HTS is a useful tool for assessing for instance pharmacological targets, pharmacologically profiling agonists and antagonists for receptors (such as GPCRs) and enzymes.

    Which product and service led the high-throughput screening market?

    The consumables segment dominated the global high-throughput screening market and held the largest revenue share of 44.85% in 2021.

    What is the regional market scenario of high-throughput screening?

    Global high-throughput screening market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for high-throughput screening. The US is estimated to hold the largest share in the high-throughput screening market during the forecast period. The growth of the market can be because of prevalence of various diseases, government support for biotechnology and increasing efforts in R&D activities as well as other activities undertaken by the market players operating in the market. In addition, technologically advanced products are likely to stimulate the growth of high-throughput screening market in North America. On the other hand, large pool of population suffering with chronic diseases, rapidly developing healthcare infrastructure, and intellectual capabilities of scientists and researchers in the Asia Pacific is expected to account for the fastest growth of the region during the coming years.

    Who are the key players in the high-throughput screening market?

    The high-throughput screening market majorly consists of the players such Agilent Technologies, Inc., Axxam S.P.A., Eurofins Scientific, Corning Incorporated, Molecular Devices, LLC., Hamilton Company, Merck Group, Perkinelmer, Inc., Tecan Group and Thermo Fisher Scientific Inc. among others.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - High Throughput Screening Market

    1. Agilent Technologies, Inc.
    2. Axxam S.P.A.
    3. Eurofins Scientific
    4. Corning Incorporated
    5. Molecular Devices, LLC.
    6. Hamilton Company
    7. Merck Group
    8. Perkinelmer, Inc.
    9. Tecan Group
    10. Thermo Fisher Scientific Inc.
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo